Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Cancer. 2013 Oct 24;120(3):344–351. doi: 10.1002/cncr.28421

Table 2.

Adverse Events by Number of Episodes

AE Category 0 1 2 3 4 5 Total
Leukopenia 32 2 1 1 0 0 36
Thrombocytopenia 28 8 0 0 0 0 36
Anemia 21 7 7 1 0 0 36
Other Hematologic 33 2 1 0 0 0 36
Allergy/Immunology 23 11 2 0 0 0 36
Auditory/Ear 29 0 6 1 0 0 36
Cardiac 15 6 9 5 1 0 36
Coagulation 35 0 0 1 0 0 36
Constitutional 12 10 13 1 0 0 36
Dermatologic 17 14 4 1 0 0 36
Endocrine 33 2 1 0 0 0 36
Gastrointestinal 6 10 15 5 0 0 36
Genitourinary/Renal 29 5 1 1 0 0 36
Hemorrhage 17 18 0 1 0 0 36
Infection 23 0 11 2 0 0 36
Lymphatics 31 4 1 0 0 0 36
Metabolic 13 10 8 3 2 0 36
Musculoskeletal 30 5 1 0 0 0 36
Neurosensory 21 13 1 1 0 0 36
Other Neurological 22 12 1 1 0 0 36
Ocular/Visual 30 6 0 0 0 0 36
Pain 1 11 16 8 0 0 36
Pulmonary 12 20 1 3 0 0 36
Sexual/Reproductive 32 4 0 0 0 0 36
Syndromes 35 1 0 0 0 0 36
Vascular 35 0 1 0 0 0 36
Death, Not CTC coded 35 0 0 0 0 1 36